2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through CA2+-dependent and -independent mechanisms
about
Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brainThe molecular connections between the cannabinoid system and endometriosisThe endocannabinoid arachidonyl ethanolamide (anandamide) increases pulmonary arterial pressure via cyclooxygenase-2 products in isolated rabbit lungs2-arachidonoylglycerol induces the migration of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes through the cannabinoid CB2 receptor-dependent mechanismEvidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cellsNeuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity.Localization of the cannabinoid CB1 receptor and the 2-AG synthesizing (DAGLα) and degrading (MAGL, FAAH) enzymes in cells expressing the Ca(2+)-binding proteins calbindin, calretinin, and parvalbumin in the adult rat hippocampus.Activation of TRPC6 channels promotes endocannabinoid biosynthesis in neuronal CAD cells.Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.Cannabinoid receptors as target for treatment of osteoporosis: a tale of two therapies.Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites.The endocannabinoid system as a target for the treatment of visceral obesity and metabolic syndrome.Quantification of anandamide, oleoylethanolamide and palmitoylethanolamide in rodent brain tissue using high performance liquid chromatography-electrospray mass spectroscopy.Endocannabinoids and diacylglycerol kinase activity.Critical enzymes involved in endocannabinoid metabolismRole of cannabinoids in the regulation of bone remodelingCompartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line.Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFkappaB activity.Brain 2-Arachidonoylglycerol Levels Are Dramatically and Rapidly Increased Under Acute Ischemia-Injury Which Is Prevented by Microwave Irradiation.P2X7 receptors control 2-arachidonoylglycerol production by microglial cells.Fatty Acid modulation of the endocannabinoid system and the effect on food intake and metabolism.CB2 receptors as new therapeutic targets for liver diseasesElucidating cannabinoid biology in zebrafish (Danio rerio).The endocannabinoid system and liver diseases.Monoacylglycerol Analysis Using MS/MS(ALL) Quadruple Time of Flight Mass SpectrometryEndocannabinoid-mediated control of synaptic transmission.Production of endocannabinoids by activated T cells and B cells modulates inflammation associated with delayed-type hypersensitivity.Fatty acid amide signaling molecules.Group XV phospholipase A₂, a lysosomal phospholipase A₂.Quantitative metabolic profiling of lipid mediators.Endocannabinoid system as a potential mechanism for n-3 long-chain polyunsaturated fatty acid mediated cardiovascular protection.Cannabinoids and the Kidney: Effects in Health and Disease.Biased Type 1 Cannabinoid Receptor Signaling Influences Neuronal Viability in a Cell Culture Model of Huntington Disease.Cannabinoid signaling in health and disease.Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on MigraineEndocannabinoid CB1 receptor-mediated rises in Ca(2+) and depolarization-induced suppression of inhibition within the laterodorsal tegmental nucleus.Dopamine activation of endogenous cannabinoid signaling in dorsal striatum.Cell type-specific regulation of inhibition via cannabinoid type 1 receptors in rat neocortex.Derivatives of monoglycerides as apoptotic agents in T-cells.15-Lipoxygenase metabolism of 2-arachidonylglycerol. Generation of a peroxisome proliferator-activated receptor alpha agonist.
P2860
Q24299523-FEA52906-91E1-4A0B-BE74-D0532A7023C5Q27005719-7475041D-65AD-497D-A704-3FF47FB33A80Q28185785-BDCC0179-CE4B-45EA-876C-22BDB57BFDEAQ28200894-0D728C50-81D2-452E-BA04-302FED8A9334Q28378272-A60CCD40-21FB-4217-AB47-A5195DCDC4C2Q30493991-84BAC09E-8211-40BB-A56B-394C633DE3CAQ33814030-AC92D4D2-B389-41AD-A54E-3CE3DC7855EDQ33961812-399E8B52-814A-442F-8D51-C3A1B26B5689Q34138944-ED2033A4-0697-448C-8EB9-44D75BAD1BB5Q34402180-90EFC920-2D5E-4370-A57F-9169D7AEDF97Q34471868-34E40E59-6E9A-4ACD-AD8D-D5844EE0B241Q34587990-BB762F92-29AB-477D-B787-BB38494D87CDQ34659846-5E3634D3-D198-45E2-A109-AEFD26667A0DQ34696352-BD3DCC35-8DF7-473F-831C-CF095E49E2D2Q35924804-AC587BE9-7BF5-444C-A302-621DD186C4BDQ36404379-A1E495D9-0922-435C-8F99-772E9D1AF0A3Q36416357-F3731CA2-2899-4EF5-B440-0EBAFA22BBEFQ36734402-62C5601C-78D1-44EA-B1D7-7FF5C7AA3AD4Q36759329-A10D7EF7-51D0-4F19-824A-F0C22242FF3DQ36854779-A52DC5B1-5B32-4846-8DCF-5C5353066CBAQ36916109-D91507E2-D211-4039-AD8B-7736190F0D00Q36977545-7D428E50-4357-4D3D-93F7-DDF85D625001Q37090161-B0E1076B-17A3-4631-8823-25DAC19811B2Q37143574-9634E4AC-4532-4BE5-B879-95571FE82DF3Q37294154-D3C3D248-7AAF-4516-AEF6-7B10876A05E1Q37363621-BC8B48E2-8F1F-42EE-BCD2-A3BF19BA2D23Q37551092-82B10755-92E6-41E3-841C-0D13D3567355Q37785382-661D52B2-D70D-42F4-8DBD-DEBA974FE9DBQ37809218-68179BD7-9148-41EF-BECA-EC6D9CA6BF4DQ38119472-BB9BDD7B-8AE9-436A-90B2-B75C772439BCQ38135915-9A28BBCA-DB87-4E96-A6CB-E65DF1ADE623Q38651395-684B5B87-D239-4AE9-A040-B7EDBDFD2906Q38809361-DFFC281D-146E-40AE-94AE-6A70441995ECQ39163671-00A65011-712F-4F75-93DD-F835CB6EDA27Q41572995-39E0F376-D3A0-428A-9E26-A8C9D246757FQ41602438-12DC73E2-C7F7-4548-B85D-6EAD3DDCD840Q41646203-0FA8B99D-0A48-4885-BC76-FBD794DE7239Q42731454-4AECB0BE-2F28-4DA9-9407-4392CF571E00Q43785728-0D2FAA39-03C8-4FE7-8F6F-F6C892624745Q43961283-192F921F-B2ED-4C30-9558-97770BF1FC01
P2860
2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through CA2+-dependent and -independent mechanisms
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
2-Arachidonoylglycerol, an end ...... nt and -independent mechanisms
@ast
2-Arachidonoylglycerol, an end ...... nt and -independent mechanisms
@en
2-Arachidonoylglycerol, an end ...... nt and -independent mechanisms
@nl
type
label
2-Arachidonoylglycerol, an end ...... nt and -independent mechanisms
@ast
2-Arachidonoylglycerol, an end ...... nt and -independent mechanisms
@en
2-Arachidonoylglycerol, an end ...... nt and -independent mechanisms
@nl
prefLabel
2-Arachidonoylglycerol, an end ...... nt and -independent mechanisms
@ast
2-Arachidonoylglycerol, an end ...... nt and -independent mechanisms
@en
2-Arachidonoylglycerol, an end ...... nt and -independent mechanisms
@nl
P2093
P921
P3181
P1433
P1476
2-Arachidonoylglycerol, an end ...... nt and -independent mechanisms
@en
P2093
A Tokumura
P3181
P356
10.1016/S0014-5793(98)00581-X
P407
P577
1998-06-12T00:00:00Z